Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gut check: dialysis Patients' microbiome under the microscope

NCT ID NCT06877585

Knowledge-focused Sponsor: Tungs' Taichung Metroharbour Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 58 adults on hemodialysis to understand how the mix of bacteria in their gut relates to waste products in their blood. Researchers measured different types of gut bacteria and chemicals they produce, like short-chain fatty acids and uremic toxins. The goal was to learn more about these connections, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

58 people

The number who actually took part.

Started

Apr 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

hemodialysis patients

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age 18-80 years and * diagnosed with CKD stage V * currently receiving hemodialysis treatment\>3 months Exclusion Criteria: * pregnant or nursing women * patients with kidney transplant * severe infections * severe cardiac diseases * liver diseases * malignancy * autoimmune disorders * severe malnutrition * consumed any type of pre-or probiotics * had antibiotic therapy within 1 month * diagnosed irritable bowel syndrome * Crohn's disease * ulcerative colitis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease Dysbiosis end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dysbiosis

Contacts and locations

Locations

  • Tungs' Taichung Metroharbour Hospital

    Taichung, Wuqi District, 435, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.